Published in Age Ageing on July 01, 2002
Assessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: a systematic review and meta-analysis. Br J Gen Pract (2006) 2.28
Diagnosis of heart failure in primary care. Heart Fail Rev (2006) 1.03
Screening for left ventricular systolic dysfunction using GP-reported ECGs. Br J Gen Pract (2007) 0.76
B-type natriuretic peptide-guided therapy for perioperative medicine? Open Heart (2014) 0.75
Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial. Lancet (2010) 4.74
Adapting clinical guidelines to take account of multimorbidity. BMJ (2012) 4.18
Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation (2002) 3.72
Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol (2004) 3.67
Does the ratio of serum aldosterone to plasma renin activity predict the efficacy of diuretics in hypertension? Results of RENALDO. J Hypertens (2010) 2.73
The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial. Circ Heart Fail (2010) 2.68
What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol (2004) 2.62
Risk factors and risk assessment tools for falls in hospital in-patients: a systematic review. Age Ageing (2004) 2.57
Improving the primary prevention of cardiovascular events by using biomarkers to identify individuals with silent heart disease. J Am Coll Cardiol (2012) 2.47
Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial. JAMA Intern Med (2013) 2.37
Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity. Age Ageing (2012) 2.26
Why older people do not participate in leisure time physical activity: a survey of activity levels, beliefs and deterrents. Age Ageing (2004) 2.20
Health and welfare of older people in care homes. BMJ (2007) 2.14
Peripheral blood pressure measurement is as good as applanation tonometry at predicting ascending aortic blood pressure. J Hypertens (2003) 2.12
Including older people in clinical research. BMJ (2005) 2.01
Effects of exercise on depressive symptoms in older adults with poorly responsive depressive disorder: randomised controlled trial. Br J Psychiatry (2002) 1.99
Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens (2009) 1.95
Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris. J Am Coll Cardiol (2011) 1.88
Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease. J Am Soc Nephrol (2011) 1.85
Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol (2004) 1.76
When "no" might not quite mean "no"; the importance of informed and meaningful non-consent: results from a survey of individuals refusing participation in a health-related research project. BMC Health Serv Res (2007) 1.69
Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure. J Am Coll Cardiol (2002) 1.64
Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis. J Am Coll Cardiol (2011) 1.60
Pulse wave analysis and pulse wave velocity: a critical review of their strengths and weaknesses. J Hypertens (2003) 1.60
Spironolactone use and renal toxicity: population based longitudinal analysis. BMJ (2010) 1.59
The effect of metformin on insulin resistance and exercise parameters in patients with heart failure. Eur J Heart Fail (2012) 1.54
Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: randomized, controlled trial. Hypertension (2014) 1.53
Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial. CMAJ (2007) 1.51
The impact of renin-angiotensin-aldosterone system blockade on heart failure outcomes and mortality in patients identified to have aortic regurgitation: a large population cohort study. J Am Coll Cardiol (2011) 1.51
The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism? J Hypertens (2002) 1.51
The cardiovascular risk factor, left ventricular hypertrophy, is highly prevalent in stable, treated angina pectoris. Am J Hypertens (2007) 1.50
Effect of Metformin on mortality in patients with heart failure and type 2 diabetes mellitus. Am J Cardiol (2010) 1.50
High-potency statin and ezetimibe use and mortality in survivors of an acute myocardial infarction: a population-based study. Heart (2014) 1.45
Instrument for objective assessment of appropriateness of surgical bed occupancy: validation study. BMJ (2003) 1.45
Effect of spironolactone on physical performance in older people with self-reported physical disability. Am J Med (2013) 1.45
Time course for recovery of atrial mechanical and endocrine function post DC cardioversion for persistent atrial fibrillation. Int J Cardiol (2005) 1.45
Spironolactone has antiarrhythmic activity in ischaemic cardiac patients without cardiac failure. J Hypertens (2007) 1.44
Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clin Infect Dis (2004) 1.43
Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure. J Am Coll Cardiol (2009) 1.41
Renin-angiotensin system blockers are associated with reduced mortality and heart failure hospitalization in patients paced for complete atrioventricular block. Heart Rhythm (2011) 1.41
Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy. Clin Sci (Lond) (2002) 1.31
Heart failure in frail elderly patients: diagnostic difficulties, co-morbidities, polypharmacy and treatment dilemmas. Eur J Heart Fail (2002) 1.27
Adverse cardiovascular effects of acute salt loading in young normotensive individuals. Hypertension (2008) 1.27
Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women. J Bone Miner Res (2007) 1.25
Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress. Vasc Health Risk Manag (2009) 1.24
How to get older people included in clinical studies. Drugs Aging (2007) 1.18
High-dose allopurinol reduces left ventricular mass in patients with ischemic heart disease. J Am Coll Cardiol (2013) 1.16
Impact of allopurinol use on urate concentration and cardiovascular outcome. Br J Clin Pharmacol (2011) 1.16
Myocardial production of C-type natriuretic peptide in chronic heart failure. Circulation (2003) 1.06
The feasibility of using pedometers and brief advice to increase activity in sedentary older women--a pilot study. BMC Health Serv Res (2008) 1.05
Mortality in people diagnosed with type 2 diabetes at an older age: a systematic review. Age Ageing (2006) 1.04
Effect of a seated exercise program to improve physical function and health status in frail patients > or = 70 years of age with heart failure. Am J Cardiol (2005) 1.02
Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice. Eur Heart J (2012) 1.02
Assessment of arterial stiffness, a translational medicine biomarker system for evaluation of vascular risk. Cardiovasc Ther (2008) 1.00
Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal. Arthritis Rheum (2012) 1.00
Interventions to enhance adherence to medications in patients with heart failure: a systematic review. Circ Heart Fail (2012) 1.00
Allopurinol treatment reduces arterial wave reflection in stroke survivors. Cardiovasc Ther (2008) 0.99
Sarcopenia--a potential target for Angiotensin-converting enzyme inhibition? Gerontology (2006) 0.99
Diagnosis of type 2 diabetes at an older age: effect on mortality in men and women. Diabetes Care (2004) 0.98
Overcoming barriers to recruitment in health research: concerns of potential participants need to be dealt with. BMJ (2006) 0.97
Targeting the renin-angiotensin-aldosterone system in heart failure. Nat Rev Cardiol (2013) 0.95
Nutritional supplementation of very old people at hospital discharge increases muscle strength: a randomised controlled trial. Gerontology (2005) 0.92
The role of urate and xanthine oxidase inhibitors in cardiovascular disease. Cardiovasc Ther (2008) 0.92
Optimization of the contrast dose and injection rates in whole-body MR angiography at 3.0T. J Magn Reson Imaging (2009) 0.92
Efficacy and cost of an exercise program for functionally impaired older patients with heart failure: a randomized controlled trial. Circ Heart Fail (2012) 0.91
Relation of QT interval dispersion to the number of different cardiac abnormalities in diabetes mellitus. Am J Cardiol (2002) 0.91
Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities. Am Heart J (2009) 0.91
Effects of exogenous and endogenous natriuretic peptides on forearm vascular function in chronic heart failure. Arterioscler Thromb Vasc Biol (2004) 0.91
Pulmonary hypertension predicts all-cause mortality in patients with heart failure: a retrospective cohort study. Eur J Heart Fail (2011) 0.90
A qualitative theory guided analysis of stroke survivors' perceived barriers and facilitators to physical activity. Disabil Rehabil (2013) 0.88
Effects of vitamin D supplementation on markers of vascular function after myocardial infarction--a randomised controlled trial. Int J Cardiol (2012) 0.88
Ageing and vitamin D deficiency: effects on calcium homeostasis and considerations for vitamin D supplementation. Br J Nutr (2009) 0.87
Mineralocorticoid antagonism: a novel way to treat sarcopenia and physical impairment in older people? Clin Endocrinol (Oxf) (2011) 0.86
B-type natriuretic peptide is an independent predictor of endothelial function in man. Clin Sci (Lond) (2012) 0.85
Left ventricular hypertrophy in COPD without hypoxemia: the elephant in the room? Chest (2013) 0.85
Introducing a new role for BNP: as a general indicator of cardiac structural disease rather than a specific indicator of systolic dysfunction only. Heart (2002) 0.85
The association between serum urate levels and arterial stiffness/endothelial function in stroke survivors. Atherosclerosis (2008) 0.85
Effects of an exercise intervention for older heart failure patients on caregiver burden and emotional distress. Eur J Cardiovasc Prev Rehabil (2006) 0.84
A systematic review of perceived barriers and motivators to physical activity after stroke. Int J Stroke (2012) 0.84
Predictors of exercise capacity and everyday activity in older heart failure patients. Eur J Heart Fail (2005) 0.83
ACE inhibitors for sarcopenia--as good as exercise training? Age Ageing (2008) 0.83
A critical re-appraisal of different ways of selecting ambulatory patients with suspected heart failure for echocardiography. Eur J Heart Fail (2006) 0.83
The prevalence of treatable left ventricular systolic dysfunction in patients who present with noncardiac vascular episodes: a case-control study. J Am Coll Cardiol (2002) 0.83
Meta-analysis of B-type natriuretic peptide's ability to identify stress induced myocardial ischemia. Am J Cardiol (2010) 0.83
Evidence based medicine, guidelines and common sense. Age Ageing (2004) 0.83
Elevated levels of natriuretic peptides in patients with pulmonary thromboembolism. Respir Med (2005) 0.83